A meta-analysis of H2R antagonist treatment combined with antipsychotic treatment in patients with schizophrenia showed that H2R antagonist adjuvant therapy did not improve psychotic symptoms but increased the risk of depression (only two comparisons with nizatidine) (86). The gene discussed is HRH2; the disease is major depressive disorder.